Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials

BACKGROUND: This retrospective pooled analysis assessed the effect of age on the efficacy and safety of trabectedin in young and elderly patients with recurrent advanced soft tissue sarcoma (STS). METHODS: Data from 350 adults with STS treated in five phase II trials with trabectedin were divided in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Cesne, A L, Judson, I, Maki, R, Grosso, F, Schuetze, S, Mehren, M V, Chawla, S P, Demetri, G D, Nieto, A, Tanovic, A, Blay, J-Y
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2013
Teme:
Clinical Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3790176/
https://ncbi.nlm.nih.gov/pubmed/24022187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.524
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki